Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy

Bassam H. Rimawi(WakeMed), Rana Chakraborty(Mayo Clinic), Erica L. Johnson(Morehouse School of Medicine), Raymond F. Schinazi(Children's Healthcare of Atlanta), Sijia Tao(Shanghai Innovative Research Center of Traditional Chinese Medicine), Scott Gillespie(Emory University), Yong Jiang(Boston University), Augustine Rajakumar(Emory University), Mark Mirochnick(Boston University), Martina L. Badell
Antimicrobial Agents and Chemotherapy
March 28, 2017
10.1128/aac.02213-16
Cited by 42

Related Papers

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
|The Lancet|2003|525
Zika Virus Infects Human Placental Macrophages
|Cell Host & Microbe|2016|494
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
|AIDS|2001|422
In Vitro Anti-HIV Activity of Biflavonoids Isolated from<i>Rhus succedanea</i>and<i>Garcinia multiflora</i>
|Journal of Natural Products|1997|278